China Oral Industry Group Holdings Limited
HKEX:8406.HK
0.065 (HKD) • At close October 15, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 166.917 | 212.519 | 294.917 | 260.735 | 223.831 | 192.977 | 176.81 | 172.347 | 168.802 | 174.809 |
| Cost of Revenue
| 139.882 | 194.948 | 235.06 | 185.824 | 171.437 | 144.139 | 135.79 | 133.426 | 136.775 | 144.476 |
| Gross Profit
| 27.035 | 17.571 | 59.857 | 74.911 | 52.394 | 48.838 | 41.02 | 38.921 | 32.027 | 30.333 |
| Gross Profit Ratio
| 0.162 | 0.083 | 0.203 | 0.287 | 0.234 | 0.253 | 0.232 | 0.226 | 0.19 | 0.174 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.034 | 0.39 |
| General & Administrative Expenses
| 19.593 | 24.165 | 21.59 | 20.03 | 14.625 | 14.936 | 15.102 | 12.268 | 11.32 | 12.937 |
| Selling & Marketing Expenses
| 20.174 | 23.461 | 31.653 | 25.487 | 13.385 | 8.347 | 10.596 | 9.269 | 9.599 | 9.485 |
| SG&A
| 39.767 | 47.626 | 53.243 | 45.517 | 28.01 | 23.283 | 25.698 | 21.537 | 22.026 | 23.196 |
| Other Expenses
| 0.485 | -0.914 | -0.53 | -0.833 | -0.367 | 0.198 | 0.066 | 0.489 | 0 | 0 |
| Operating Expenses
| 39.715 | 46.712 | 52.713 | 44.684 | 27.643 | 22.134 | 25.298 | 21.122 | 22.113 | 22.529 |
| Operating Income
| -12.732 | -21.541 | 8.451 | 30.583 | 25.589 | 28.853 | 17.562 | 23.147 | 10.001 | 7.137 |
| Operating Income Ratio
| -0.076 | -0.101 | 0.029 | 0.117 | 0.114 | 0.15 | 0.099 | 0.134 | 0.059 | 0.041 |
| Total Other Income Expenses Net
| -5.676 | -14.227 | -5.616 | -2.029 | -1.511 | -4.014 | -3.59 | -8.464 | 0.535 | 1.043 |
| Income Before Tax
| -18.408 | -35.768 | 2.835 | 28.554 | 24.078 | 24.839 | 13.972 | 14.683 | 10.536 | 8.18 |
| Income Before Tax Ratio
| -0.11 | -0.168 | 0.01 | 0.11 | 0.108 | 0.129 | 0.079 | 0.085 | 0.062 | 0.047 |
| Income Tax Expense
| 0.218 | -0.917 | 4.968 | 4.997 | 5.196 | 3.577 | 4.423 | 5.258 | 3.174 | 2.411 |
| Net Income
| -18.626 | -34.851 | -2.133 | 23.557 | 18.882 | 21.262 | 9.549 | 9.425 | 7.362 | 5.769 |
| Net Income Ratio
| -0.112 | -0.164 | -0.007 | 0.09 | 0.084 | 0.11 | 0.054 | 0.055 | 0.044 | 0.033 |
| EPS
| -0.019 | -0.042 | -0.003 | 0.029 | 0.024 | 0.027 | 0.014 | 0.014 | 0.011 | 0.009 |
| EPS Diluted
| -0.019 | -0.042 | -0.003 | 0.029 | 0.024 | 0.027 | 0.014 | 0.014 | 0.011 | 0.009 |
| EBITDA
| -2.84 | -14.757 | 15.218 | 36.144 | 30.718 | 30.598 | 19.364 | 24.961 | 11.964 | 9.529 |
| EBITDA Ratio
| -0.017 | -0.069 | 0.052 | 0.139 | 0.137 | 0.159 | 0.11 | 0.145 | 0.071 | 0.055 |